Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−21.15 M USD
0.00 USD
3.84 M
About Citius Oncology, Inc.
Sector
Industry
CEO
Leonard L. Mazur
Headquarters
Cranford
Founded
2021
ISIN
US17331Y1091
FIGI
BBG01163HKY3
Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Citius Oncology, Inc. stocks are traded under the ticker CTOR.
CTOR reached its all-time high on Jul 7, 2025 with the price of 5.52 USD, and its all-time low was 0.63 USD and was reached on Apr 8, 2025. View more price dynamics on CTOR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Citius Oncology, Inc. financials in yearly and quarterly reports right on TradingView.
Citius Oncology, Inc. is going to release the next earnings report on Dec 3, 2025. Keep track of upcoming events with our Earnings Calendar.
CTOR earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.15 USD resulting in a 46.67% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Citius Oncology, Inc. earnings.
CTOR net income for the last quarter is −5.37 M USD, while the quarter before that showed −7.74 M USD of net income which accounts for 30.58% change. Track more Citius Oncology, Inc. financial stats to get the full picture.
No, CTOR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CTOR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Citius Oncology, Inc. stock right from TradingView charts — choose your broker and connect to your account.